Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis
- PMID: 20065141
- PMCID: PMC2819405
- DOI: 10.1001/archneurol.2009.299
Opsoclonus-myoclonus syndrome in anti-N-methyl-D-aspartate receptor encephalitis
Abstract
Background: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis has been recently reported as autoimmune/paraneoplastic encephalitis, affecting mostly young females.
Objective: To describe opsoclonus-myoclonus syndrome in association with anti-NMDAR antibodies.
Design: Case report.
Setting: Geneva University Hospital. Patient A 23-year-old woman with opsoclonus-myoclonus syndrome.
Results: Two weeks after an episode of gastroenteritis, the patient developed symptoms of depression associated with psychomotor slowing, progressive gait instability, and opsoclonus-myoclonus. Cerebrospinal fluid examination showed mild lymphocytic pleocytosis and intrathecal IgG synthesis with oligoclonal bands. The patient's condition worsened rapidly to an akinetic mutism, followed by a period of agitation, delirium, and hallucinations. These gradually subsided; however, a frontal behavior and executive dysfunction persisted 5 months after symptom presentation. No tumor was found. Anti-NMDAR antibodies were found in the cerebrospinal fluid.
Conclusions: Opsoclonus-myoclonus may occur in patients with anti-NMDAR encephalitis. Prompt diagnosis of this disorder is important because after tumor removal and immunomodulatory therapies it has a relatively good prognosis.
Figures

Comment in
-
Anxiety as initial diagnosis in opsoclonus myoclonus syndrome.Arch Neurol. 2010 Sep;67(9):1154-5; author reply 1155. doi: 10.1001/archneurol.2010.192. Arch Neurol. 2010. PMID: 20837866 No abstract available.
Similar articles
-
Update on opsoclonus-myoclonus syndrome in adults.J Neurol. 2019 Jun;266(6):1541-1548. doi: 10.1007/s00415-018-9138-7. Epub 2018 Nov 27. J Neurol. 2019. PMID: 30483882 Review.
-
Pediatric Opsoclonus-Myoclonus-Ataxia Syndrome Associated With Anti-N-methyl-D-aspartate Receptor Encephalitis.Pediatr Neurol. 2015 Nov;53(5):456-8. doi: 10.1016/j.pediatrneurol.2015.07.010. Epub 2015 Aug 1. Pediatr Neurol. 2015. PMID: 26341674
-
N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis.Arch Neurol. 2011 Aug;68(8):1069-72. doi: 10.1001/archneurol.2011.166. Arch Neurol. 2011. PMID: 21825245
-
N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.Brain. 2010 Jun;133(Pt 6):1655-67. doi: 10.1093/brain/awq113. Brain. 2010. PMID: 20511282 Free PMC article.
-
Anti-N-Methyl-D-Aspartate Receptor Encephalitis in Children and Adolescents.J Pediatr Health Care. 2016 Jul-Aug;30(4):347-58. doi: 10.1016/j.pedhc.2015.09.004. Epub 2015 Oct 21. J Pediatr Health Care. 2016. PMID: 26507948 Review.
Cited by
-
Update on opsoclonus-myoclonus syndrome in adults.J Neurol. 2019 Jun;266(6):1541-1548. doi: 10.1007/s00415-018-9138-7. Epub 2018 Nov 27. J Neurol. 2019. PMID: 30483882 Review.
-
Serum Biomarkers in Neuro-Ophthalmology: When to Test.Semin Ophthalmol. 2021 May 19;36(4):322-328. doi: 10.1080/08820538.2021.1897856. Epub 2021 Mar 10. Semin Ophthalmol. 2021. PMID: 33689572 Free PMC article.
-
Anti-NMDAR encephalitis presenting after immature teratoma resection.BMJ Case Rep. 2021 Nov 19;14(11):e244637. doi: 10.1136/bcr-2021-244637. BMJ Case Rep. 2021. PMID: 34799390 Free PMC article.
-
Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.JAMA Neurol. 2016 Apr;73(4):417-24. doi: 10.1001/jamaneurol.2015.4607. JAMA Neurol. 2016. PMID: 26856612 Free PMC article.
-
Anti-N-methyl-D-aspartate receptor encephalitis with minimal cortical impairment.Neurol Sci. 2013 Jan;34(1):111-3. doi: 10.1007/s10072-012-0934-z. Epub 2012 Jan 10. Neurol Sci. 2013. PMID: 22231472
References
-
- Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung NK, Dalmau J. Autoantigen diversity in the opsoclonus-myoclonus syndrome. Ann Neurol. 2003;53(3):347–353. - PubMed
-
- Markakis I, Alexiou E, Xifaras M, Gekas G, Rombos A. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase. Clin Neurol Neurosurg. 2008;110(6):619–621. - PubMed
-
- Fitzpatrick AS, Gray OM, McConville J, McDonnell GV. Opsoclonus myoclonus syndrome associated with benign ovarian teratoma. Neurology. 2008;70(15):1292–1293. - PubMed
-
- Shindo A, Kagawa K, Ii Y, Sasaki R, Kokubo Y, Kuzuhara S. Anti-N-methyl-D-aspartate receptor-related grave but reversible encephalitis with ovarian teratoma in 2 Japanese women presenting with excellent recovery without tumor resection. Eur Neurol. 2009;61(1):50–51. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical